Browse our catalogue of products
91 products displayed
| Ref-SKU | Type | Product | Description | ICTV Taxonomy | Virus name | Strain | Isolate | Product Grading | Availability | Product Risk Group | Provider | Cost per Access (Academics) | More info | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 014V-01881 | Virus |
Human Influenza B victoria virus B/Bretagne/399/2016, D197N mutation
Antiviral resistant strain, Reference Strain |
Human Influenza B victoria virus B/Bretagne/399/2016, D197N mutation, isolate of 2015-2016 epidemic season | Influenza B virus | Influenza B virus | B/Bretagne/399/2016 (B victoria) | Platinum | In stock | RG2 | IP | 1,500€ | View all details on this product . . . | Free access available | |
| 017V-05437 | Virus |
Influenza B Yamagata virus, B/Picardie/1392/2018 PA(I38T), epidemic isolate, baloxavir resistance
Antiviral resistant strain, Reference Strain |
Influenza B Yamagata virus, B/Picardie/1392/2018 PA(I38T), epidemic isolate, baloxavir resistance, 2017-2018 season | Influenza B virus | Influenza B virus | B/Picardie/1392/2018 | Platinum | In stock | RG2 | IP | 2,000€ | View all details on this product . . . | Free access available | |
| 017V-05371 | Virus |
Human Influenza A(H1N1p) virus, A/LeMans/15006/2022 epidemic isolate, PA E199D mutation
Antiviral resistant strain |
Human Influenza A(H1N1)pdm09 virus, A/LeMans/15006/2022, with PA E199D baloxavir resistance mutation, isolate of 2021-2022 epidemic season | Influenza A virus | Influenza A virus (A/LeMans/15006/2022) | A/LeMans/15006/2022 | Gold | In stock | RG2 | IP | 1,500€ | View all details on this product . . . | Free access available | |
| 017V-06226 | Virus |
Human Influenza B victoria virus B/France/IDF-RELAB-IPP14156/2024, D197N mutation
Antiviral resistant strain |
Human Influenza B victoria virus B/France/IDF-RELAB-IPP14156/2024, D197N mutation, isolate of 2024-2024 epidemic season | Influenza B virus | Influenza B virus | B/France/IDF-RELAB-IPP14156/2024 (B victoria) | Platinum | In stock | RG2 | IP | 1,500€ | View all details on this product . . . | Free access available | |
| 006V-03426 | Virus |
HIV-1_pr-L90M
Antiviral resistant strain |
L90M mutation in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus type 1 | Platinum | Upon request | RG3 | UNIBAS | 2,000€ | View all details on this product . . . | Free access available | ||
| 006N-03078 | Nucleic Acid |
HIV-1 pNL-_rtD67N
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the reverse transcriptase gene, which can confer drug resistance to specific HIV-1 inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on reverse transcriptase inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
| 006N-03073 | Nucleic Acid |
HIV-1 pNL-BX_prL63P
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with a specific mutation in the protease gene, which has been described as a polymorphic mutation. It is unclear, whether it can confer drug resistance to specific HIV-1 PR inhibitors directly. It has been shown in cell culture that the presence of the 63P change leads to higher "replicative fitness" of the virus. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Platinum | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
| 006N-03077 | Nucleic Acid |
HIV-1 pNL-BX_prM36V
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
| 006N-03074 | Nucleic Acid |
HIV-1 pNL-BX_prL90M
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
| 006N-03081 | Nucleic Acid |
HIV-1 pNL-BX_prL10I
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
| 006N-03084 | Nucleic Acid |
HIV-1 pNL-BX_pr-L33F
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
| 006N-03076 | Nucleic Acid |
HIV-1 pNL-BX_pr-L24I
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
| 006N-03083 | Nucleic Acid |
HIV-1 pNL-BX_pr-K20R
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
| 006N-03075 | Nucleic Acid |
HIV-1 pNL-BX_pr-L10F
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
| 006N-03082 | Nucleic Acid |
HIV-1 pNL-BX_pr-M46I
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the protease gene, which can confer drug resistance to specific HIV-1 PR inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on PR inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
| 006N-02608 | Nucleic Acid |
HIV-1 pNL-BX_prL63P-A71V-V82T-I84V
Antiviral resistant strain |
Protease mutant with discrete mutations relevant for drug resistance to protease inhibitors | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
| 006N-02602 | Nucleic Acid |
HIV-1 pNL-BX_prM46I-I47L-I50V-V82A-I84V
Antiviral resistant strain |
Protease mutant with the indicated discrete mutations relevant for drug resistance to protease inhibitors | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
| 006N-02575 | Nucleic Acid |
HIV-1 pNL-BX_pr84V
Antiviral resistant strain |
HIV-1, drug resistant point mutant of protease, selected by specific HIV protease inhibitors. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
| 006N-02574 | Nucleic Acid |
HIV-1 pNL-BX_pr84A
Antiviral resistant strain |
HIV-1, drug resistant point mutant of protease, selected by specific HIV protease inhibitors in vivo | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
| 006V-02640 | Virus |
HIV-1_pr84A
Antiviral resistant strain |
HIV-1 variant, infectious recombinant virus with specific mutations in the protease gene as indicated. These mutations confer resistance to specific HIV protease inhibitors and have been reported for emerging virus in vivo. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | point-mutated recombinant | Platinum | In stock | RG3 | UNIBAS | 2,000€ | View all details on this product . . . | Free access available |
| 006V-02657 | Virus |
HIV-1 pNL-BX_prK45I-L76F
Antiviral resistant strain |
HIV-1 variant, infectious recombinant virus with specific mutations in the protease gene as indicated. These mutations confer resistance to specific HIV protease inhibitors and have been reported for emerging virus in vivo. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | point-mutated recombinant | Platinum | In stock | RG3 | UNIBAS | 2,000€ | View all details on this product . . . | Free access available |
| 006N-02572 | Nucleic Acid |
HIV-1 pNL-BX_prI50L
Antiviral resistant strain |
HIV-1, drug resistant point mutant of protease, reported to be specifically selected by the HIV protease inhibitor atazanavir in vivo | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Clade B | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available | |
| 006N-03072 | Nucleic Acid |
HIV-1 pNL-BX_prV82A
Antiviral resistant strain |
Plasmid contains the entire genome of HIV-1 with specific mutations in the viral protease gene, which can confer drug resistance to specific HIV-1 protease inhibitors. The respective mutations have been reported in viruses from HIV-infected individuals on protease inhibitors with virologic therapy failure. | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Subtype B | recombinant | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
| 006N-01922 | Nucleic Acid |
HIV-1 pNL-BX_prL10F-M46I-A71V-V82A-I84V
Antiviral resistant strain |
Recombinant HIV-1 plasmid (derived from pNL4-3) with the indicated mutations in the protease gene, which have been reported in the context of clinical drug resistance to HIV protease inhibitors. | Human immunodeficiency virus 1 | Human immunodeficiency virus type 1 | clade B | The recombinant clone NL4-3 was derived from proviral DNA isolated from human HIV-1 positive cells | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |
| 006N-01921 | Nucleic Acid |
HIV-1 pNL-BX_prG48V-L90M
Antiviral resistant strain |
Recombinant HIV-1 virus with the indicated mutations in the protease gene. Mutations have been reported from drug resistant viral variants emerging in vivo, e.g. after treatment with the HIV protease inhibitor saquinavir | Human immunodeficiency virus 1 | Human immunodeficiency virus type 1 | clade B | The recombinant clone NL4-3 was derived from proviral DNA isolated from human HIV positive cells | Gold | In stock | RG2 | UNIBAS | 675€ | View all details on this product . . . | Free access available |